Legal Representation
Attorney
Julie A. Greenberg
USPTO Deadlines
Next Deadline
659 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20211109)
Due Date
November 09, 2027
Grace Period Ends
May 09, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 7, 2022 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED | Loading... |
| Jun 7, 2022 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jan 24, 2022 | ES7R | I | TEAS SECTION 7 REQUEST RECEIVED | Loading... |
| Nov 9, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 24, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 24, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 4, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 21, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 7, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jan 7, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jan 7, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Dec 4, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 4, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 2, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 4, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 4, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 4, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 12, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 12, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 12, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 12, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 4, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 4, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 4, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 4, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 29, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 29, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 29, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 29, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 27, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 27, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 23, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 20, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 3, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 3, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 3, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 27, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 10, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 30, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Strategic business consulting in the fields of market analysis, sales, and cost in the pharmacologic market segment featuring customizable economic models and underlying qualitative assumptions and particularly specializing in the use of analytic models for the understanding and predicting of trends and actions in the pharmacologic market segment; Business monitoring and consulting services in the pharmacologic market segment, namely, tracking web sites and applications of others to provide strategy, insight, market analysis, sales, and cost, particularly specializing in the use of analytic and statistic models for the understanding and predicting of trends and actions in the pharmacologic market segment, including customizable economic models and underlying qualitative assumptions; Business management consulting in the pharmacologic market segment with relation to strategy, market analysis, regulatory and policy analysis, reimbursability, and substitutability, particularly specializing in the use of analytic and statistic models for the understanding and predicting of trends and actions in the pharmacologic market segment, including customizable economic models and underlying qualitative assumptions; Analyzing and compiling business data covering products in the pharmacologic market segment featuring customizable economic models and underlying qualitative assumptions; Business data analysis in the pharmacologic market segment featuring customizable economic models and underlying qualitative assumptions; business consultation services, namely, providing drug life-cycle insights for others; business consultation services, namely, clinical, formulary, procurement, and inventory-control insights for others; economic forecasting services, namely, brand and generic market impact forecasts; medical drug coding services for others in the nature of drug and dosage administered for purposes of billing and reimbursement from insurance; business services, namely, providing business information online in the field of budget impact models in the pharmacologic market for others
First Use Anywhere:
Dec 1, 2002
First Use in Commerce:
Dec 1, 2002
Additional Information
Other
In the statement, line 4, "Aventura, MICHIGAN 48098" should be deleted, and "Aventura, FLORIDA 33180" should be inserted.
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ANALYTICS"